<DOC>
	<DOC>NCT01444287</DOC>
	<brief_summary>The purpose of this research is to measure daytime open-eye response to wearing of narafilcon B lenses.</brief_summary>
	<brief_title>Daytime Corneal Swelling During Wear of Narafilcon B Lenses</brief_title>
	<detailed_description />
	<criteria>Be of legal age (i.e. â‰¥ 18 years). Be mentally competent, willing and able to sign a written informed consent form. Have contact lens distance sphere requirement in the range 1.00D to 6.00D. Have spectacle astigmatism &lt;1.25D in each eye. Currently wear soft contact lenses (for at least 6 months prior to the trial) with documentation of current prescription. Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having: i) no evidence of lid abnormality or infection; ii) no conjunctival abnormality or infection; iii) no clinically significant slit lamp findings (i.e, edema, staining, scarring, vascularization, infiltrates or abnormal opacities); iv) no other active ocular disease. Required concurrent ocular medication. Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear. Eye injury or surgery within eight weeks immediately prior to enrollment for this study. Abnormal lacrimal secretions. Preexisting ocular irritation that would preclude contact lens fitting. Keratoconus or other corneal irregularity. Pregnancy, lactating or planning a pregnancy at the time of enrollment. Participation in any concurrent clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>